STAAR Surgical Company (STAA) Documents: SEC Filings, Investor Presentations & Press Releases

STAAR Surgical Company (STAA) documents, SEC filings and the IR site together: 201 documents, newest first; latest 2026-08-12. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-12Press releaseSTAAR Surgical Reports Second Quarter 2026 Results
2026-08-12Press releaseSTAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026
2026-08-128-KForm 8-K, Item 2.02 results
2026-08-1210-QForm 10-Q for the quarter ended Jul 3
2026-08-068-KForm 8-K, Item 5.02
2026-08-04Press releaseSTAAR Surgical Appoints Warren Foust as President and Chief Executive Officer Deborah Andrews appointed Executive Vice President and Chief Financial Officer
2026-06-228-KForm 8-K, Item 5.02
2026-06-098-KForm 8-K, Item 5.02
2026-05-21Press releaseSTAAR Surgical Announces Participation in Upcoming Investor Conferences
2026-05-21Press releaseSTAAR Surgical Announces Participation in Upcoming Investor Conferences
2026-05-21Press releasePress release · May 2026
2026-05-13Press releaseSTAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
2026-05-13Press releaseSTAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
2026-05-13Press releasePress release · Q1 2026 · May 2026
2026-05-138-KForm 8-K, Item 2.02 results
2026-05-1310-QForm 10-Q for the quarter ended Apr 3
2026-05-04Press releaseSTAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
2026-05-04Press releasePress release · Q1 2026 · May 2026
2026-05-04ProxyDefinitive proxy statement
2026-05-03ESG report2026 Sustainability Data Index Evolution in Visual Freedom
2026-05-03ESG reportInvestor document · FY 2025 · May 2026
2026-04-08Press releaseSTAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
2026-04-088-KForm 8-K, Item 7.01
2026-03-05TranscriptQ4 FY25 earnings call transcript
2026-03-03Press releaseSTAAR Surgical Issues Shareholder Letter
2026-03-03Press releasePress release · Mar 2026
2026-03-03Press releasePress release · FY 2025 · Mar 2026
2026-03-03Press releasePress release · Q4 2025 · Mar 2026
2026-03-038-KForm 8-K, Item 2.02 results
2026-03-0310-KAnnual report on Form 10-K, FY25
2026-02-25Press releaseSTAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
2026-02-23Press releaseSTAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
2026-02-23Press releasePress release · FY 2025 · Feb 2026
2026-02-058-KForm 8-K, Item 5.02
2026-02-02Press releaseSTAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs Search Committee Has Initiated a Global Search to Select Next CEO
2026-02-028-KForm 8-K, Item 5.02
2026-01-168-KForm 8-K, Item 5.02
2026-01-158-KForm 8-K, Item 1.01
2026-01-06Press releaseSTAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders STAAR Intends to Terminate Alcon Merger Agreement
2026-01-068-KForm 8-K, Item 8.01

STAA overview · STAA earnings · STAA financials · STAA KPIs · STAA ownership · STAA peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.